ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/13 | 2,825 | 2,839 | 2,789 | 2,820 | +6 | +0.2% | 103,400 |
2023/09/12 | 2,720 | 2,814 | 2,720 | 2,814 | +94 | +3.5% | 119,700 |
2023/09/11 | 2,741 | 2,748 | 2,696 | 2,720 | -21 | -0.8% | 112,000 |
2023/09/08 | 2,740 | 2,761 | 2,736 | 2,741 | +19 | +0.7% | 56,200 |
2023/09/07 | 2,726 | 2,777 | 2,712 | 2,722 | +6 | +0.2% | 105,200 |
2023/09/06 | 2,711 | 2,731 | 2,698 | 2,716 | +8 | +0.3% | 77,000 |
2023/09/05 | 2,710 | 2,724 | 2,702 | 2,708 | ±0 | ±0% | 61,200 |
2023/09/04 | 2,727 | 2,770 | 2,694 | 2,708 | -6 | -0.2% | 144,100 |
2023/09/01 | 2,714 | 2,722 | 2,690 | 2,714 | -11 | -0.4% | 117,700 |
2023/08/31 | 2,711 | 2,737 | 2,682 | 2,725 | -1 | ±0% | 111,300 |
2023/08/30 | 2,748 | 2,781 | 2,711 | 2,726 | -11 | -0.4% | 129,200 |
2023/08/29 | 2,698 | 2,746 | 2,698 | 2,737 | +52 | +1.9% | 94,200 |
2023/08/28 | 2,650 | 2,694 | 2,639 | 2,685 | +59 | +2.2% | 121,700 |
2023/08/25 | 2,630 | 2,643 | 2,575 | 2,626 | -4 | -0.2% | 79,200 |
2023/08/24 | 2,522 | 2,630 | 2,521 | 2,630 | +105 | +4.2% | 149,000 |
2023/08/23 | 2,534 | 2,548 | 2,511 | 2,525 | -9 | -0.4% | 56,800 |
2023/08/22 | 2,534 | 2,560 | 2,510 | 2,534 | +24 | +1% | 83,000 |
2023/08/21 | 2,450 | 2,519 | 2,431 | 2,510 | +56 | +2.3% | 149,800 |
2023/08/18 | 2,411 | 2,480 | 2,405 | 2,454 | +31 | +1.3% | 86,100 |
2023/08/17 | 2,460 | 2,460 | 2,381 | 2,423 | -27 | -1.1% | 177,500 |
2023/08/16 | 2,458 | 2,503 | 2,450 | 2,450 | -8 | -0.3% | 139,800 |
2023/08/15 | 2,520 | 2,527 | 2,432 | 2,458 | -43 | -1.7% | 235,300 |
2023/08/14 | 2,341 | 2,544 | 2,339 | 2,501 | +226 | +9.9% | 502,200 |
2023/08/10 | 2,032 | 2,354 | 2,010 | 2,275 | +215 | +10.4% | 544,300 |
2023/08/09 | 2,098 | 2,098 | 2,038 | 2,060 | -8 | -0.4% | 53,000 |
2023/08/08 | 2,090 | 2,091 | 2,059 | 2,068 | -8 | -0.4% | 37,400 |
2023/08/07 | 2,049 | 2,078 | 2,041 | 2,076 | +46 | +2.3% | 30,100 |
2023/08/04 | 2,078 | 2,078 | 2,025 | 2,030 | -51 | -2.5% | 98,700 |
2023/08/03 | 2,090 | 2,106 | 2,078 | 2,081 | -19 | -0.9% | 43,600 |
2023/08/02 | 2,104 | 2,132 | 2,098 | 2,100 | -13 | -0.6% | 35,600 |
2023/08/01 | 2,108 | 2,135 | 2,108 | 2,113 | +10 | +0.5% | 27,300 |
2023/07/31 | 2,105 | 2,120 | 2,094 | 2,103 | +8 | +0.4% | 34,600 |
2023/07/28 | 2,110 | 2,118 | 2,088 | 2,095 | -35 | -1.6% | 56,400 |
2023/07/27 | 2,154 | 2,154 | 2,119 | 2,130 | -15 | -0.7% | 52,900 |
2023/07/26 | 2,161 | 2,161 | 2,122 | 2,145 | -10 | -0.5% | 39,300 |
2023/07/25 | 2,130 | 2,164 | 2,117 | 2,155 | +32 | +1.5% | 68,100 |
2023/07/24 | 2,126 | 2,130 | 2,107 | 2,123 | +17 | +0.8% | 33,500 |
2023/07/21 | 2,093 | 2,141 | 2,091 | 2,106 | +30 | +1.4% | 119,100 |
2023/07/20 | 2,074 | 2,090 | 2,065 | 2,076 | +2 | +0.1% | 47,400 |
2023/07/19 | 2,069 | 2,092 | 2,064 | 2,074 | +15 | +0.7% | 47,000 |
2023/07/18 | 2,043 | 2,071 | 2,043 | 2,059 | +16 | +0.8% | 31,500 |
2023/07/14 | 2,034 | 2,047 | 2,017 | 2,043 | +4 | +0.2% | 44,600 |
2023/07/13 | 2,035 | 2,042 | 2,019 | 2,039 | +7 | +0.3% | 60,800 |
2023/07/12 | 2,055 | 2,062 | 2,031 | 2,032 | -23 | -1.1% | 78,800 |
2023/07/11 | 2,064 | 2,083 | 2,053 | 2,055 | -13 | -0.6% | 36,400 |
2023/07/10 | 2,076 | 2,076 | 2,060 | 2,068 | -8 | -0.4% | 36,100 |
2023/07/07 | 2,050 | 2,086 | 2,034 | 2,076 | +16 | +0.8% | 64,100 |
2023/07/06 | 2,080 | 2,088 | 2,055 | 2,060 | -31 | -1.5% | 95,800 |
2023/07/05 | 2,091 | 2,093 | 2,069 | 2,091 | ±0 | ±0% | 63,800 |
2023/07/04 | 2,102 | 2,107 | 2,081 | 2,091 | -15 | -0.7% | 66,200 |
301~
350
件表示中 / 2191件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 156,900円 | -5.1% | -21.2% | 5.10% | 9.91倍 | 1.89倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ハートシード | 150,300円 | +154.1% | - | 0.00% | - | 7.36倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ダイト | 212,900円 | +4.5% | -10.8% | 3.29% | 14.16倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
扶桑薬 | 255,500円 | +8.3% | +98.1% | 3.21% | 8.39倍 | 0.58倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
セルソース | 102,500円 | -3.0% | -55.9% | 0.49% | 48.69倍 | 3.36倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム